← Eichor
Study identifier: NCT06964568 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Condition: Esophageal Carcinoma · Radiotherapy · Immunotherapy  ·  Sponsor: Fudan University

PhasePhase 3
Planned participants452
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.

This description comes directly from the study's public registry record.

Talk to the study team

Kuaile Zhao, MD  ·  +86-21-64175590  ·  kuaile_z@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fudan University Shanghai Cancer CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06964568